Update on the Withdrawal from Long-term Use of Benzodiazepines in Patients with Chronic Insomnia Disorder

doi:10.12114/j.issn.1007-9572.2022.0341

Abstract

Abstract:

Benzodiazepines (BZDs) are indicated for the short-term treatment of chronic insomnia disorder, since real-world use of them in large doses for a long time could cause serious side effects. Patients with long-term use of BZDs are prone to BZDs tolerance and dependence, but sudden withdrawal from BZDs can lead to rebound and withdrawal symptoms, resulting in difficulty in withdrawal. We reviewed recent studies about the withdrawal from long-term use of BZDs in chronic insomnia disorder patients, focusing on the overview of BZDs, timing and strategy of withdrawal, and treatment of withdrawal symptoms. Our review will contribute to enriching the ideas of appropriately discontinuing BZDs in chronic insomnia disorder patients with long-term use of BZDs.

Key words: Sleep disorders, Insomnia, Benzodiazepines, Discontinuation, Withdrawal symptoms, Review

摘要：

苯二氮䓬类（BZDs）药物适用于慢性失眠障碍的短期治疗，长期大剂量使用可导致严重的不良反应。患者长期应用BZDs可产生耐受性和依赖性，突然停药可出现反跳现象和戒断症状，导致停药困难。因此本文整理分析了目前慢性失眠障碍患者长期使用BZDs停药的相关文献，分别从BZDs概述、停药时机和策略、停药治疗等方面进行综述，旨在为长期使用BZDs的慢性失眠障碍患者如何合理停用BZDs提供借鉴。

关键词: 睡眠障碍, 失眠症, 苯二氮?类, 停药, 戒断症状, 综述

Jinxiang CHENG,Liping ZHANG,Changjun SU. Update on the Withdrawal from Long-term Use of Benzodiazepines in Patients with Chronic Insomnia Disorder[J]. Chinese General Practice, 2022, 25(27): 3347-3351. DOI: 10.12114/j.issn.1007-9572.2022.0341.
程金湘,张丽萍,宿长军. 慢性失眠障碍患者长期使用苯二氮䓬类药物停药的研究进展[J]. 中国全科医学, 2022, 25(27): 3347-3351. DOI: 10.12114/j.issn.1007-9572.2022.0341.

References 45

[1]	POTTIE K，THOMPSON W，DAVIES S，et al. Deprescribing benzodiazepine receptor agonists：evidence-based clinical practice guideline[J]. Can Fam Physician，2018，64（5）：339-351.
[2]	BRAUER R，ALFAGEH B，BLAIS J E，et al. Psychotropic medicine consumption in 65 countries and regions，2008-19：a longitudinal study[J]. Lancet Psychiatry，2021，8（12）：1071-1082. DOI：10.1016/S2215-0366(21)00292-3.
[3]	LEE M H，CHOI J W，LEE J，et al. Trends in prescriptions for sedative-hypnotics among Korean adults：a nationwide prescription database study for 2011-2015[J]. Soc Psychiatry Psychiatr Epidemiol，2019，54（4）：477-484. DOI：10.1007/s00127-018-1615-x.
[4]	XU L，LV X Z，WANG H L，et al. Trends in psychotropic medication prescriptions in urban China from 2013 to 2017：national population-based study[J]. Front Psychiatry，2021，12：727453. DOI：10.3389/fpsyt.2021.727453.
[5]	ALBRECHT J S，WICKWIRE E M，VADLAMANI A，et al. Trends in insomnia diagnosis and treatment among medicare beneficiaries，2006-2013[J]. Am J Geriatr Psychiatry，2019，27（3）：301-309. DOI：10.1016/j.jagp.2018.10.017.
[6]	CROWE S F，STRANKS E K. The residual medium and long-term cognitive effects of benzodiazepine use：an updated meta-analysis[J]. Arch Clin Neuropsychol，2018，33（7）：901-911. DOI：10.1093/arclin/acx120.
[7]	POLY T N，ISLAM M M，YANG H C，et al. Association between benzodiazepines use and risk of hip fracture in the elderly people：a meta-analysis of observational studies[J]. Joint Bone Spine，2020，87（3）：241-249. DOI：10.1016/j.jbspin.2019.11.003.
[8]	SEPPALA L J，WERMELINK A M A T，DE VRIES M，et al. Fall-risk-increasing drugs：a systematic review and meta-analysis：Ⅱ. psychotropics[J]. J Am Med Dir Assoc，2018，19（4）：371.e11-371.e17. DOI：10.1016/j.jamda.2017.12.098.
[9]	SMINK B E，EGBERTS A C，LUSTHOF K J，et al. The relationship between benzodiazepine use and traffic accidents：a systematic literature review[J]. CNS Drugs，2010，24（8）：639-653. DOI：10.2165/11533170-000000000-00000.
[10]	PENNINKILAMPI R，ESLICK G D. A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use，after controlling for protopathic bias[J]. CNS Drugs，2018，32（6）：485-497. DOI：10.1007/s40263-018-0535-3.
[11]	KLEINMAN R A，WEISS R D. Benzodiazepine-involved overdose deaths in the USA：2000-2019[J]. J Gen Intern Med，2022，37（8）：2103-2109. DOI：10.1007/s11606-021-07035-6.
[12]	MURPHY Y，WILSON E，GOLDNER E M，et al. Benzodiazepine use，misuse，and harm at the population level in Canada：a comprehensive narrative review of data and developments since 1995[J]. Clin Drug Investig，2016，36（7）：519-530. DOI：10.1007/s40261-016-0397-8.
[13]	中华医学会神经病学分会，中华医学会神经病学分会睡眠障碍学组. 中国成人失眠诊断与治疗指南（2017版）[J]. 中华神经科杂志，2018，51（5）：324-335. DOI：10.3760/cma.j.issn.1006-7876.2018.05.002.
[14]	中国睡眠研究会. 中国失眠症诊断和治疗指南[J]. 中华医学杂志，2017，97（24）：1844-1856. DOI：10.3760/cma.j.issn.0376-2491.2017.24.002.
[15]	SATEIA M J，BUYSSE D J，KRYSTAL A D，et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults：an American academy of sleep medicine clinical practice guideline[J]. J Clin Sleep Med，2017，13（2）：307-349. DOI：10.5664/jcsm.6470.
[16]	RIEMANN D，BAGLIONI C，BASSETTI C，et al. European guideline for the diagnosis and treatment of insomnia[J]. J Sleep Res，2017，26（6）：675-700. DOI：10.1111/jsr.12594.
[17]	SOYKA M. Treatment of benzodiazepine dependence[J]. N Engl J Med，2017，376（12）：1147-1157. DOI：10.1056/nejmra1611832.
[18]	BUSCEMI N，VANDERMEER B，FRIESEN C，et al. The efficacy and safety of drug treatments for chronic insomnia in adults：a meta-analysis of RCTs[J]. J Gen Intern Med，2007，22（9）：1335-1350. DOI：10.1007/s11606-007-0251-z.
[19]	PARRINO L，TERZANO M G. Polysomnographic effects of hypnotic drugs. A review[J]. Psychopharmacology，1996，126（1）：1-16. DOI：10.1007/BF02246405.
[20]	VINKERS C H，OLIVIER B. Mechanisms underlying tolerance after long-term benzodiazepine use：a future for subtype-selective GABA（A） receptor modulators?[J]. Adv Pharmacol Sci，2012，2012：416864. DOI：10.1155/2012/416864.
[21]	NURMINEN J，PUUSTINEN J，LÄHTEENMÄKI R，et al. Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam，zopiclone or zolpidem as hypnotics[J]. BMC Geriatr，2014，14：121. DOI：10.1186/1471-2318-14-121.
[22]	DELL'OSSO B，LADER M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal[J]. Eur Psychiatry，2013，28（1）：7-20. DOI：10.1016/j.eurpsy.2011.11.003.
[23]	GUINA J，MERRILL B. BenzodiazepinesⅡ：waking up on sedatives：providing optimal care when inheriting benzodiazepine prescriptions in transfer patients[J]. J Clin Med，2018，7（2）：E20. DOI：10.3390/jcm7020020.
[24]	CURRAN H V，COLLINS R，FLETCHER S，et al. Older adults and withdrawal from benzodiazepine hypnotics in general practice：effects on cognitive function，sleep，mood and quality of life[J]. Psychol Med，2003，33（7）：1223-1237. DOI：10.1017/s0033291703008213.
[25]	BAILLARGEON L，LANDREVILLE P，VERREAULT R，et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering：a randomized trial[J]. CMAJ，2003，169（10）：1015-1020.
[26]	BELLEVILLE G，GUAY C，GUAY B，et al. Hypnotic taper with or without self-help treatment of insomnia：a randomized clinical trial[J]. J Consult Clin Psychol，2007，75（2）：325-335. DOI：10.1037/0022-006X.75.2.325.
[27]	GARFINKEL D，ZISAPEL N，WAINSTEIN J，et al. Facilitation of benzodiazepine discontinuation by melatonin：a new clinical approach[J]. Arch Intern Med，1999，159（20）：2456-2460. DOI：10.1001/archinte.159.20.2456.
[28]	HABRAKEN H，SOENEN K，BLONDEEL L，et al. Gradual withdrawal from benzodiazepines in residents of homes for the elderly：experience and suggestions for future research[J]. Eur J Clin Pharmacol，1997，51（5）：355-358. DOI：10.1007/s002280050213.
[29]	MORIN C M，BASTIEN C，GUAY B，et al. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia[J]. Am J Psychiatry，2004，161（2）：332-342. DOI：10.1176/appi.ajp.161.2.332.
[30]	PAT-HORENCZYK R，HACOHEN D，HERER P，et al. The effects of substituting zopiclone in withdrawal from chronic use of benzodiazepine hypnotics[J]. Psychopharmacology（Berl），1998，140（4）：450-457. DOI：10.1007/s002130050789.
[31]	SHAPIRO C，SHERMAN D，PECK D. Withdrawal from benzodiazepines by initially switching to zopiclone[J]. Eur Psychiatry，1995，10（Suppl3）：145s-151s. DOI：10.1016/0924-9338(96)80096-4.
[32]	VISSERS F H J A，KNIPSCHILD P G，CREBOLDER H F J M. Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial[J]. Pharm World Sci，2007，29（6）：641-646. DOI：10.1007/s11096-007-9118-y.
[33]	DIAPER A M，LAW F D，MELICHAR J K. Pharmacological strategies for detoxification[J]. Br J Clin Pharmacol，2014，77（2）：302-314. DOI：10.1111/bcp.12245.
[34]	VORMA H，NAUKKARINEN H，SARNA S，et al. Treatment of out-patients with complicated benzodiazepine dependence：comparison of two approaches[J]. Addiction，2002，97（7）：851-859. DOI：10.1046/j.1360-0443.2002.00129.x.
[35]	BAANDRUP L，EBDRUP B H，RASMUSSEN J Ø，et al. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users[J]. Cochrane Database Syst Rev，2018，3：CD011481. DOI：10.1002/14651858.CD011481.pub2.
[36]	GUO F，YI L，ZHANG W，et al. Association between Z drugs use and risk of cognitive impairment in middle-aged and older patients with chronic insomnia[J]. Front Hum Neurosci，2021，15：775144. DOI：10.3389/fnhum.2021.775144.
[37]	DONNELLY K，BRACCHI R，HEWITT J，et al. Benzodiazepines，Z-drugs and the risk of hip fracture：a systematic review and meta-analysis[J]. PLoS One，2017，12（4）：e0174730. DOI：10.1371/journal.pone.0174730.
[38]	TREVES N，PERLMAN A，KOLENBERG GERON L，et al. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis[J]. Age Ageing，2018，47（2）：201-208. DOI：10.1093/ageing/afx167.
[39]	SWEETMAN A，PUTLAND S，LACK L，et al. The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use：a narrative review[J]. Sleep Med Rev，2021，56：101404. DOI：10.1016/j.smrv.2020.101404.
[40]	PUUSTINEN J，LÄHTEENMÄKI R，NURMINEN J，et al. Long-term persistence of withdrawal of temazepam，zopiclone，and zolpidem in older adults：a 3-year follow-up study[J]. BMC Geriatr，2018，18（1）：142. DOI：10.1186/s12877-018-0829-9.
[41]	WILSON S，ANDERSON K，BALDWIN D，et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia，parasomnias and circadian rhythm disorders：an update[J]. J Psychopharmacol，2019，33（8）：923-947. DOI：10.1177/0269881119855343.
[42]	CROKE L. Deprescribing benzodiazepine receptor agonists for insomnia in adults[J]. Am Fam Physician，2019，99（1）：57-58.
[43]	HINTZE J P，EDINGER J D. Hypnotic discontinuation in chronic insomnia[J]. Sleep Med Clin，2020，15（2）：147-154. DOI：10.1016/j.jsmc.2020.02.003.
[44]	DARKER C D，SWEENEY B P，BARRY J M，et al. Psychosocial interventions for benzodiazepine harmful use，abuse or dependence[J]. Cochrane Database Syst Rev，2015（5）：CD009652. DOI：10.1002/14651858.CD009652.pub2.
[45]	YEUNG W F，CHUNG K F，ZHANG Z J，et al. Electroacupuncture for tapering off long-term benzodiazepine use：a randomized controlled trial[J]. J Psychiatr Res，2019，109：59-67. DOI：10.1016/j.jpsychires.2018.11.015.